Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Disease area: Respiratory infections

Abstract

A retrospective study on a group of 417 children with TB and HIV/AIDS; 165 among these have had (+) culture for TB; MDR-TB - diagnosed to 73 children – 32,12%. Results: Mean age – 14,5 years; Sex – M: 50,94%; F: 49%; TST positive > 5 mm – 51,5%; negative – 49,5%; associated clinical symptoms: fever, weight loss, irritability – 100%; pain throat 75%, haemoptysia 50%.
Rx abnormalities: parenchymal infiltration – 36,4%; cavitary lesions – 37%, hilar opacities – 11,3%; miliary – 7,5% bronchopneumonic opacities – 7,5%.
Extrapulmonary TB – pleural effusion – 10,6,%; meningitis – 19,43%.
Decreased CD4 – value <200 cells/mm3 – 32%, <100 cells/mm3 – 58,49%, <50 cells/mm3 – 9,43%. The cultures (+) in the sputum – 42,5%; gastric aspiration – 28,3%; LCR - 9,4%.
BAAR presence: in sputum - 45,2%; LCR - 9,4%; gastric aspiration - 28,3%; pleural liquid – 3%, ganglionar aspiration - 13,1%. Chemo resistant forms: primary – 18,9%; secondary - 81,1%. Other resistances associated to H, R: SM-29,5%; PZM-24,3%; EMB-18,9%;Km-13,5%;CS-8,1%; Q -5,4%
Used treatment protocol 18-24 months; 4-5 antiTB drugs. Antiretroviral treatment received – 157% children.
\Side effects of treatment: hepatic cytolytic syndrome – 35,1%; jaundice - 18,9%; hadeache – 16,2%; personality disorders – 16,2%; thrombocytopenia – 13,5%.
Bacteriological situation of discharge last BK examination BK cultures negative – 71,4%; positive - 28,86%.
Conclusions: The MDR-TB prevalence is increased in the HIV/AIDS infected children; more frequent in the children with multiple hospitals admittance with previously antituberculous treatments, history of inappropriate regimes drugs,preventive therapies,treatment interruptions, treatment with two drugs.


Rating:

Share or cite this content

Citations should be made in the following way:
G. Murgoci, R. Murgoci, C. Marica, M. Tanasescu, G. Nini, H. Stavri, M. Mardarescu, M. Luminos (Bucharest, Arad, Romania). Multidrug-resistant TB in children with HIV infection in Romania. Eur Respir J 2011; 38: Suppl. 55, 1935

Member's Comments

No comment yet.

Related content which might interest you: Multidrug-resistant TB in children with HIV infection Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007 Multidrug-resistant tuberculosis (MDR-TB) and HIV co-infection in Romania Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Multidrug-resistant tuberculosis and HIV infection in Eastern Europe: Two overlapping epidemics Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Particularities of tuberculosis at children hospitalized with HIV co-infection Source: Annual Congress 2009 - Tuberculosis at different age groups Year: 2009 Multidrug-resistant tuberculosis in children of Belarus Source: Virtual Congress 2021 – The ongoing threat of drug-resistant tuberculosis Year: 2021 Recurrent tuberculosis among HIV infected persons in Singapore Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017 Drug-resistant tuberculosis among foreign-born persons in Italy Source: Eur Respir J 2012; 40: 497-500 Year: 2012 HIV and multidrug-resistant tuberculosis: overlapping epidemics Source: Eur Respir J 2014; 44: 251-254 Year: 2014 TB situation in Bulgaria – epidemiology, TB-HIV co-infection Source: Eur Respir J 2006; 28: Suppl. 50, 16s Year: 2006 Multidrug-resistant tuberculosis: eight years of surveillance in France Source: Eur Respir J 2003; 22: 833-837 Year: 2003 Consideration about chemoresistant TB incidence at HIV infected children in Romania Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008 Tuberculosis for HIV infected patients in Latvia Source: Eur Respir J 2001; 18: Suppl. 33, 314s Year: 2001 Evaluation of the multidrug resistant TB in children with HIV infection Source: Eur Respir J 2004; 24: Suppl. 48, 439s Year: 2004 The (in)significance of TB and COVID-19 co-infection Source: Eur Respir J, 56 (2) 2002105; 10.1183/13993003.02105-2020 Year: 2020 Trends of TB and HIV infections on endemic territory of Kazakhstan Source: Eur Respir J 2004; 24: Suppl. 48, 196s Year: 2004 HIV seroprevalence among tuberculosis patients in Tripoli Libya Source: Eur Respir J 2004; 24: Suppl. 48, 197s Year: 2004 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 Recurrent tuberculosis infection in prisons of Belarus Source: Eur Respir J 2003; 22: Suppl. 45, 344s Year: 2003 Screening for latent tuberculosis infection among healthcare workers in Bulgaria Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017